Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Olímpia Fonseca"'
Autor:
António Cabral Lopes, Olga Lourenço, Sandra Morgado, Andreia Gaspar, Idalina Freire, Inês Eusébio, João Ribeiro, Mafalda Silva, Marta Mendes, Olímpia Fonseca, Rute Duarte, Manuel Morgado
Publikováno v:
Pharmaceuticals, Vol 17, Iss 4, p 420 (2024)
Dapagliflozin, a sodium–glucose cotransporter 2 inhibitor (SGLT2i), has shown demonstrated benefits for renal and cardiovascular outcomes in large clinical trials. However, short-term concerns regarding its impact on renal function and electrolyte
Externí odkaz:
https://doaj.org/article/ce6f1d88edb84ef498f862bffcd6851e
Autor:
Jorge Aperta, Andrea Borges, Diana Cadilha, Francisca Dimas, Cristina Dinis, José Feio, Olímpia Fonseca, Martinha Garcia, Filomena Marques, João Ribeiro, Celina Rodrigues, Cláudia Santos, Carmo Teixeira, Klára Dimitrovová
Publikováno v:
Revista Portuguesa de Farmacoterapia, Vol 7, Iss 4, Pp 14-20 (2015)
The centralization of purchases has been increasingly a strategic trend, particularly in the health sector. In Portugal, the SPMS, Serviços Partilhados do Ministério da Saúde, E.P.E., was established in 2010 as a central purchasing entity for the
Externí odkaz:
https://doaj.org/article/daa7e1b53ed94c32ba0a00b7e5c12984
Autor:
Jorge Aperta, Andrea Borges, Diana Cadilha, Francisca Dimas, Cristina Dinis, José Feio, Olímpia Fonseca, Martinha Garcia, Filomena Marques, João Ribeiro, Celina Rodrigues, Cláudia Santos, Carmo Teixeira, Klara Dimitrovová
Publikováno v:
Revista Portuguesa de Farmacoterapia, Vol 7, Iss 4 (2016)
A centralização das compras tem vindo a ser cada vez mais uma tendência estratégica, nomeadamente no setor da saúde. Em Portugal, a SPMS, Serviços Partilhados do Ministério da Saúde, E.P.E., foi constituída em 2010 como uma central de compra
Externí odkaz:
https://doaj.org/article/f0aed55a684c4c8db64ecc73b7d5c172
Publikováno v:
Drugs & Therapy Perspectives. 38:222-234
Publikováno v:
Drug information and pharmacotherapy.
Background According to the assessment report of the European Medicines Agency (EMA, 2014), colistimethate sodium is considered a crucial therapeutic option in the context of infections caused by multiresistant gram negative pathogens. This report pr
Autor:
A.C. Ramalhinho, Inês Eusébio, Patricia Amantegui, Rita Oliveira, Rita Moras, Olímpia Fonseca, Jorge Martinez, João Ribeiro
Publikováno v:
Thrombosis Research. 130:S140-S141
Publikováno v:
Thrombosis Research. 131:S98
Autor:
A.C. Ramalhinho, Rita Moras, Jorge Martinez, Olímpia Fonseca, João Ribeiro, Rita Oliveira, Patricia Amantegui, Inês Eusébio
Publikováno v:
Thrombosis Research. 130:S141
Publikováno v:
Thrombosis Research. 129:S177
s / Thrombosis Research 129, Supplement 1 (2012) S155–S194 S177 Abstract PO-41 – Table 1. Catheter outcomes, by devicePO-41 – Table 1. Catheter outcomes, by device n=95 PICCs n=51 CVCs Number Percentage (%) Number Percentage (%) Male 48 50.5% 3